Brief: CStone Pharmaceuticals Announces Publication Of Results From Phase III Agile Trial Of Tibsovo
22/04/2022 02:18
April 22 (Reuters) - CStone Pharmaceuticals 2616.HK :
* ANNOUNCE PUBLICATION OF RESULTS FROM PHASE III AGILE TRIAL
OF
TIBSOVO
* GLOBAL PHASE III TRIAL OF TIBSOVO MET ITS PRIMARY ENDPOINT
OF
EVENT- FREE SURVIVAL AND ALL KEY SECONDARY ENDPOINTS
Source text for Eikon: ID:nHKSPKJ86
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026